Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late Phase 2 Double-Blind Study of JTZ-951 (enarodustat) in Anemic Hemodialysis Patients
jRCT2080222840Phase 2Completed
- Sponsor
- Japan Tobacco
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anaemia comparing JTZ-951 (enarodustat) with Placebo (2 arms). Primary endpoint: Proportion of subjects maintaining hemoglobin within baseline ±1.0 g/dL at endpoint. Started May 2015; status: completed.
02
Drugs
enarodustat
03
Conditions
anaemia
Beyond the preview
Go deeper on jRCT2080222840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222840.